Relapse-free survival and ROC curve analysis.

<p>Proposed candidate biomarkers better predicted relapse-free survival (p = 0.01191) <b>(A)</b> as compared to AFP (P = 0.1987) <b>(B)</b>. With respect to the discriminating ability of proposed biomarkers, long rank equal curve showed statistically significant p-value (<0.05) for HCC p = 0.02361 while for cirrhotic liver p-value was 0.1985 (which not significant) (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0138913#pone.0138913.g009" target="_blank">Fig 9A and 9B</a>).